Contents

Current Pharmaceutical Design, Volume 18 - Number 32

Editorial

Editorial: [Hot Topic: Cannabis and Psychosis: Targeting Potential Treatments]

, 18(32): 4889

Stefan Borgwardt


DOI: 10.2174/138161212802884771




Psychopharmacological Boundaries of Schizophrenia with Comorbid Cannabis Use Disorder: A Critical Review

, 18(32): 4890 - 4896

Judit Lazary


DOI: 10.2174/138161212802884654




Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review

, 18(32): 4897 - 4905

Derik Hermann and Miriam Schneider


DOI: 10.2174/138161212802884825




Cannabis in the Arm: What Can we Learn from Intravenous Cannabinoid Studies?

, 18(32): 4906 - 4914

Amir Englund, James M. Stone and Paul D. Morrison


DOI: 10.2174/138161212802884618




The Effect of Cannabis on Perception of Time: A Critical Review

, 18(32): 4915 - 4922

Zerrin Atakan, Paul Morrison, Matthijs G. Bossong, Rocio Martin-Santos and Jose A. Crippa


DOI: 10.2174/138161212802884852




Treatment of Cannabis Use Among People with Psychotic Disorders: A Critical Review of Randomised Controlled Trials

, 18(32): 4923 - 4937

Amanda L. Baker, Louise K. Thornton, Leanne Hides and Adrian Dunlop


DOI: 10.2174/138161212802884834




Neurophysiological Effects of Cannabinoids: Implications for Psychosis Research

, 18(32): 4938 - 4949

Jurgen Gallinat, Johannes Rentzsch and Patrik Roser


DOI: 10.2174/138161212802884582




Why do Psychotic Patients use Cannabis? Case Series

, 18(32): 4950 - 4959

Anna Kolliakou, Khalida Ismail and Zerrin Atakan


DOI: 10.2174/138161212802884807




Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia

, 18(32): 4960 - 4965

Raquel Levin, Valeria Almeida, Fernanda Fiel Peres, Mariana Bendlin Calzavara, Neide Derci da Silva, Mayra Akimi Suiama, Suzy Tamie Niigaki, Antonio Waldo Zuardi, Jaime Eduardo Cecilio Hallak, Jose Alexandre Crippa and Vanessa Costhek Abilio


DOI: 10.2174/138161212802884735




Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

, 18(32): 4966 - 4979

R. Martin-Santos, J. A. Crippa, A. Batalla, S. Bhattacharyya, Z. Atakan, S. Borgwardt, P. Allen, M. Seal, K. Langohr, M. Farre, AW. Zuardi and P. K. McGuire


DOI: 10.2174/138161212802884780




The Endocannabinoid System and Schizophrenia: Integration of Evidence

, 18(32): 4980 - 4990

Erica Zamberletti, Tiziana Rubino and Daniela Parolaro


DOI: 10.2174/138161212802884744




Cannabis Use and Psychosis: Theme Introduction

, 18(32): 4991 - 4998

Giovanni Martinotti, Giuseppe Di Iorio, Gianna Sepede, Domenico De Berardis, Luisa De Risio and Massimo Di Giannantonio


DOI: 10.2174/138161212802884627




Neurocognitive Functioning and Cannabis Use in Schizophrenia

, 18(32): 4999 - 5007

Aviv Segev and Shaul Lev-Ran


DOI: 10.2174/138161212802884799




Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research

, 18(32): 5008 - 5014

Kerri A. Schoedel and Sarah Jane Harrison


DOI: 10.2174/138161212802884708




Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: Critical Review and Future Directions

, 18(32): 5015 - 5023

Jeroen Decoster, Jim van Os, Inez Myin-Germeys, Marc De Hert and Ruud van Winkel


DOI: 10.2174/138161212802884591




Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis

, 18(32): 5024 - 5035

Jose Maria Pelayo-Teran, Paula Suarez-Pinilla, Nicholas Chadi and Benedicto Crespo-Facorro


DOI: 10.2174/138161212802884609




Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

, 18(32): 5036 - 5044

Floor J. van der Meer, Eva Velthorst, Carin J. Meijer, Marise W.J. Machielsen and Lieuwe de Haan


DOI: 10.2174/138161212802884762




Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging Studies

, 18(32): 5045 - 5054

Sagnik Bhattacharyya, Zerrin Atakan, Rocio Martin-Santos, Jose A. Crippa and Philip K. McGuire


DOI: 10.2174/138161212802884636




The Association between Cannabis Use and Earlier Age at Onset of Schizophrenia and other Psychoses: Meta-analysis of Possible Confounding Factors

, 18(32): 5055 - 5069

Nicholas Myles, Hannah Newall, Olav Nielssen and Matthew Large


DOI: 10.2174/138161212802884816




Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies

, 18(32): 5070 - 5080

Charlotte Rapp, Hilal Bugra, Anita Riecher-Rossler, Corinne Tamagni and Stefan Borgwardt


DOI: 10.2174/138161212802884861




Resting State Abnormalities in Psychosis Compared to Acute Cannabinoids and Opioids Challenges: A Systematic Review of Functional Imaging Studies

, 18(32): 5081 - 5092

Niklaus Denier, Marc Walter, Kerstin Bendfeldt and Undine Lang


DOI: 10.2174/138161212802884717




Cannabis use and Duration of Untreated Psychosis: A Systematic Review and Meta-Analysis

, 18(32): 5093 - 5104

Jonathan K. Burns


DOI: 10.2174/138161212802884672




Patient’s Perceptions of the Cannabis-psychosis Link - A Systematic Review

, 18(32): 5105 - 5112

Anna Buadze, Stefan Kaiser, Rudolf Stohler, Wulf Roessler, Erich Seifritz and Michael Liebrenz


DOI: 10.2174/138161212802884645




The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia

, 18(32): 5113 - 5130

J. C. Arnold, A. A. Boucher and T. Karl


DOI: 10.2174/138161212802884726




A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

, 18(32): 5131 - 5140

Antonio Waldo Zuardi, Jose Alexandre S. Crippa, Jaime E.C. Hallak, Sagnik Bhattacharyya, Zerrin Atakan, Rocio Martin-Santos, Philip K. McGuire and Francisco Silveira Guimaraes


DOI: 10.2174/138161212802884681




Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies

, 18(32): 5141 - 5155

Patrik Roser and Ida S. Haussleiter


DOI: 10.2174/138161212802884690




Neurological Soft Signs in Patients with Psychosis and Cannabis Abuse: A Systematic Review and Meta-Analysis of Paradox

, 18(32): 5156 - 5164

Miguel Ruiz-Veguilla, Luis F. Callado and Maite Ferrin


DOI: 10.2174/138161212802884753




Can Cannabis Increase the Suicide Risk in Psychosis? A Critical Review

, 18(32): 5165 - 5187

Gianluca Serafini, Maurizio Pompili, Marco Innamorati, Zoltan Rihmer, Leo Sher and Paolo Girardi


DOI: 10.2174/138161212802884663




Anandamide Dysfunction in Prodromal and Established Psychosis

, 18(32): 5188 - 5193

F. Markus Leweke


DOI: 10.2174/138161212802884843




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science